Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EBT (2016 - 2025)

Historic EBT for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $61.8 million.

  • Prestige Consumer Healthcare's EBT fell 2288.1% to $61.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $266.7 million, marking a year-over-year decrease of 391.6%. This contributed to the annual value of $284.2 million for FY2025, which is 295.77% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its EBT stood at $61.8 million for Q4 2025, which was down 2288.1% from $69.1 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's EBT's 5-year high stood at $80.2 million during Q4 2024, with a 5-year trough of -$299.5 million in Q1 2023.
  • Moreover, its 5-year median value for EBT was $67.7 million (2022), whereas its average is $48.1 million.
  • In the last 5 years, Prestige Consumer Healthcare's EBT tumbled by 59130.16% in 2023 and then skyrocketed by 12247.65% in 2024.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's EBT stood at $65.5 million in 2021, then increased by 4.01% to $68.1 million in 2022, then increased by 2.14% to $69.6 million in 2023, then increased by 15.21% to $80.2 million in 2024, then dropped by 22.88% to $61.8 million in 2025.
  • Its EBT stands at $61.8 million for Q4 2025, versus $69.1 million for Q3 2025 and $61.8 million for Q2 2025.